Ecuador vs Naoero: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Naoero
100.0%
in 2023
Ecuador rank
1st
Naoero rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Naoero
How they compare
Ecuador currently reports 100.0% against 100.0% in Naoero, a difference of 0.0%.
The two have swapped places 1 time across 9 shared years of data; in 2011 it was Ecuador ahead.
Ecuador ranks 1st and Naoero ranks 1st of 192 countries.
Ecuador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.8% | 0.0% | 29.8% | Ecuador |
| 2020s | 94.8% | 75.0% | 19.8% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Naoero?
- Ecuador, at 100.0% against 100.0% in Naoero as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Naoero?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Naoero?
- 9 years are reported by both, from 2011 to 2023.
- How do Ecuador and Naoero rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Naoero ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.